Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAVE as Treatment for Radiation-Induced Erectile Dysfunction
NCT03830164Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2019
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of atorvastatin, vitamin e and pentoxifylline in erectile dysfunction (ED), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: International Index of Erectile Function at 12 months. Started Nov 2019; status: completed.
02
Drugs
atorvastatinvitamin epentoxifylline
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT03830164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03830164.